Valbiotis
About:
Valbiotis develops nutrition solutions to prevent cardio metabolic diseases and provides nutritional support for patients.
Website: http://valbiotis.com/
Twitter/X: valbiotis
Top Investors: Sofimac Investment Managers
Description:
Valbiotis develops nutrition solutions to prevent cardio metabolic diseases and provides nutritional support for patients. The company develops Valedia, a product that is in Phase II clinical trials for the treatment of type 2 diabetes.
Total Funding Amount:
26.5M EUR
Estimated Revenue Range:
$10M to $50M
Headquarters Location:
La Rochelle, Poitou-Charentes, France
Founded Date:
2014-01-01
Founders:
Jocelyn Pineau, Sebastien PELTIER
Number of Employees:
11-50
Last Funding Date:
2022-11-09
IPO Status:
Public
Industries:
© 2025 bioDAO.ai